TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.730
+0.360 (8.24%)
At close: Jun 26, 2026, 4:00 PM EDT
4.820
+0.090 (1.90%)
After-hours: Jun 26, 2026, 6:25 PM EDT
TriSalus Life Sciences Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for TriSalus Life Sciences stock have an average target of 8.80, with a low estimate of 7.00 and a high estimate of 11. The average target predicts an increase of 86.05% from the current stock price of 4.73.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TriSalus Life Sciences stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 5 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 6 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $7 | Buy | Maintains | $7 | +47.99% | Jun 25, 2026 |
| Lake Street | Lake Street | Buy Reiterates $8 | Buy | Reiterates | $8 | +69.13% | May 29, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $10 | Buy | Reiterates | $10 | +111.42% | May 14, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $11 | Buy | Reiterates | $11 | +132.56% | May 13, 2026 |
| Northland Securities | Northland Securities | Buy Reiterates $13 → $8 | Buy | Reiterates | $13 → $8 | +69.13% | Mar 23, 2026 |
Financial Forecast
Revenue This Year
52.40M
from 45.15M
Increased by 16.05%
Revenue Next Year
78.41M
from 52.40M
Increased by 49.65%
EPS This Year
-0.45
EPS Next Year
-0.25
from -0.45
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 54.1M | 91.8M | |
| Avg | 52.4M | 78.4M | |
| Low | 48.6M | 70.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 19.8% | 75.2% | |
| Avg | 16.0% | 49.6% | |
| Low | 7.6% | 33.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.45 | -0.25 | |
| Avg | -0.45 | -0.25 | |
| Low | -0.45 | -0.25 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.